Cipla and Stempeutics collaborate for launch of Stempeucel(R),...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MUMBAI, India, August 21 /PRNewswire-AsiaNet/ -- - First approved allogeneic cell therapy product globally for the treatment of CLI- Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost- Cipla t...
Authors: LATEST ASIANET NEWS RELEASES